Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases

BACKGROUND: Radiation therapy with radium-223 dichloride improves overall survival, reduces symptomatic skeletal events in Caucasian patients with castration-resistant prostate cancer (CRPC) and bone metastases, and is well tolerated. We report here the results of the first efficacy and safety study...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Clin Oncol
Autors principals: Uemura, Hiroji, Uemura, Hirotsugu, Matsubara, Nobuaki, Kinuya, Seigo, Hosono, Makoto, Yajima, Yoko, Doi, Toshihiko
Format: Artigo
Idioma:Inglês
Publicat: Springer Japan 2017
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5608784/
https://ncbi.nlm.nih.gov/pubmed/28478485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10147-017-1130-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars